Detailed Information on Publication Record
2019
Lipidic Liquid Crystalline Cubic Phases and Magnetocubosomes as Methotrexate Carriers
MIERZWA, Monika, Adrianna CYTRYNIAK, Pawel KRYSINSKI and Renata BILEWICZBasic information
Original name
Lipidic Liquid Crystalline Cubic Phases and Magnetocubosomes as Methotrexate Carriers
Authors
MIERZWA, Monika, Adrianna CYTRYNIAK, Pawel KRYSINSKI and Renata BILEWICZ
Edition
Nanomaterials, BASEL, MDPI, 2019, 2079-4991
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
21000 2.10 Nano-technology
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.324
UT WoS
000467768800152
Keywords in English
methotrexate; cubic phase; magnetocubosomes; monoolein; liquid crystalline phase; drug delivery system; alternating magnetic field
Tags
Tags
International impact, Reviewed
Změněno: 11/6/2024 09:28, Mgr. Eva Dubská
Abstract
V originále
The release profiles of methotrexate, an anticancer drug, from the monoolein liquid crystalline cubic phases were studied. The cubic phases were used either in the form of a lipidic film deposited onto a glassy carbon electrode surface or in the dispersed form of magnetocubosomes, which are considered a prospective hybrid drug delivery system. Commonly, cubosomes or liposomes are employed, but not in the case of toxic methotrexate, known to block the receptors responsible for folate transport into the cells. The release profiles of the drug from the lipidic films were monitored electrochemically and described using the Higuchi model. They were also modified via changes in temperature; the release was faster, although it deviated from the model when the temperature was increased. Cubic phase nanoparticles (magnetocubosomes) containing hydrophobic magnetic nanoparticles placed in an alternating magnetic field of low frequency and amplitude, stimulated drug release from the suspension, which was monitored spectroscopically. These new biocompatible hybrid nanomaterials in the dispersed form allow to control the release of the drug at the appropriate sites, can be easily separated or relocated under external magnetic field and await further investigations of their in vitro cytotoxicity and in vivo biodistribution.
Links
90127, large research infrastructures |
|